Modified Albumin-Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy.

Cancers (Basel) · 2022 · PMC9600636 · PMID 36291867

Europe PMC DOI

hedged sentence

0.1270

closest p · 2.5× alpha

0.1270

boldest claim

The sentences

did not reach statistical significancep = 0.127not close (p > 0.1)

2 did not reach statistical significance ( p = 0.127) in Model 1 ( Table S2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.